You are here:     > Celebrating 40 Years of Business Excellence

Celebrating 40 Years of Business Excellence


40 years ago, we embarked on a mission to enrich patients’ lives. It began as a series of small steps. The learnings that came with experience helped us fine-tune our strategies and forge ahead. Over time, we built up momentum and grew rapidly to become what we are today: a billion dollar-plus company with over 13,500 employees in 50 countries and deriving more than 70% of our revenues from overseas.


Through this journey, we have marked a number of significant milestones. This includes the creation of a range of stalwart brands in focus areas such as dermatology and respiratory, which have attained leadership position in India and earned the loyalty of prescribers and patients alike in international markets. Our commitment to affordable, high-quality medicines has spawned a successful, global generics business that has helped patients and payers reduce healthcare costs with its range of off-patent versions of blockbuster and niche innovator brands approved by the world’s toughest regulators. With our new drug research and development programme, we are now closer than ever in our quest to become a global, innovation-led pharmaceutical company that provides novel solutions to patients facing challenging health conditions. Our over a decade-long investment in R&D is yielding breakthrough new molecules that are in various stages of development for patients suffering from different types of cancer and other debilitating diseases. Our focus on adding value to patients through incremental innovation has brought us closer to the global launch of our first branded, specialty pharmaceutical product.

These achievements embolden us to envisage the future with optimism and confidence. For those who believed in us through good and bad times, we would like to thank you for your faith and guidance. We hope that you will continue to support us in this exciting journey.